Evidence map›Paper›PMID 31986878›Full record

ArticleAnalytical chemistry2020

Integration of High-Resolution Radiation Detector for Hybrid Microchip Electrophoresis.

Jason Jones, Noel S Ha, Alec G Barajas, Arion F Chatziioannou, R Michael van Dam

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jason JonesCrump Institute for Molecular Imaging and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , California 90095 , United States.ORCID 0000-0003-0140-1087
Noel S HaCrump Institute for Molecular Imaging and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , California 90095 , United States.ORCID 0000-0002-3275-577X
Alec G BarajasCrump Institute for Molecular Imaging and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , California 90095 , United States.
Arion F ChatziioannouCrump Institute for Molecular Imaging and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , California 90095 , United States.
R Michael van DamCrump Institute for Molecular Imaging and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , California 90095 , United States.
University of California, Los Angeles · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Research Training in Biomedical PhysicsT32EB002101 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Michael F McNitt-Gray · 2003 to 2026
$5.3M
Automated microfluidic production of high specific activity PET tracers to enable routine CNS imagingR21AG049918 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VAN DAM, ROBERT MICHAEL · 2015 to 2017
$693k
High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancerR21CA212718 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VAN DAM, ROBERT MICHAEL · 2017 to 2018
$616k
Novel microscale purification methods for complete microfluidic production of high molar activity PET radiotracersR21EB024243 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VAN DAM, ROBERT MICHAEL · 2019 to 2020
$429k
NCI NIH HHS P30 CA016042NCI NIH HHS R21 CA212718NIA NIH HHS R21 AG049918NIBIB NIH HHS R21 EB024243NIBIB NIH HHS T32 EB002101
6 · The paper itself

Abstract

For decades, there has been immense progress in miniaturizing analytical methods based on electrophoresis to improve sensitivity and to reduce sample volumes, separation times, and/or equipment cost and space requirements, in applications ranging from analysis of biological samples to environmental analysis to forensics. In the field of radiochemistry, where radiation-shielded laboratory space is limited, there has been great interest in harnessing the compactness, high efficiency, and speed of microfluidics to synthesize short-lived radiolabeled compounds. We recently proposed that analysis of these compounds could also benefit from miniaturization and have been investigating capillary electrophoresis (CE) and hybrid microchip electrophoresis (hybrid-MCE) as alternatives to the typically used high-performance liquid chromatography (HPLC). We previously showed separation of the positron-emission tomography (PET) imaging tracer 3'-deoxy-3'-fluorothymidine (FLT) from its impurities in a hybrid-MCE device with UV detection, with similar separation performance to HPLC, but with improved speed and lower sample volumes. In this paper, we have developed an integrated radiation detector to enable measurement of the emitted radiation from radiolabeled compounds. Though conventional radiation detectors have been incorporated into CE systems in the past, these approaches cannot be readily integrated into a compact hybrid-MCE device. We instead employed a solid-state avalanche photodiode (APD)-based detector for real-time, high-sensitivity β particle detection. The integrated system can reliably separate [

Indexed as

Electrophoresis, MicrochipChromatography, LiquidDideoxynucleosidesFluorine RadioisotopesDideoxynucleosidesFluorine Radioisotopes

Identifiers

PMID31986878
PMCPMC7410349
OpenAlexW3003168560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.